Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 6/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | HTR2B | P41595 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11599328 | 0.86 | LMNA (0.39) | CA1CA2GABRA1GABRB1GABRB2 | |
| SCHEMBL4712954 | 0.79 | GABRA1 (0.52) | CA1CA2GABRA1GABRB1GABRB2 | |
| SCHEMBL1760529 | 0.78 | CA1 (0.70) | CA1CA2GABRA1GABRB1GABRB2 | |
| SCHEMBL461449 | 0.78 | CA1 (0.55) | CA1CA2GABRA1GABRB1GABRB2 | |
| SCHEMBL4907457 | 0.78 | GABRA1 (0.50) | CA1CA2GABRA1GABRB1GABRB2 | |
| SCHEMBL2155116 | 0.78 | ALDH1A1 (0.38) | CA1CA2GABRA1GABRB1GABRB2 | |
| SCHEMBL29926096 | 0.76 | CA1 (0.52) | CA1CA2GABRA1GABRB1GABRB2 | |
| Hydrochloric Acid SCHEMBL5431425 | 0.76 | GAA (0.38) | CA1CA2GABRA1GABRB1GABRB2 | |
| SCHEMBL3435343 | 0.76 | CA1 (0.46) | CA1CA2GABRA1GABRB1GABRB2 | |
| SCHEMBL3440745 | 0.76 | GABRA1 (0.50) | CA1CA2GABRA1GABRB1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12466903-B2 | Catalysts and process for olefins and polar vinyl monomers copolymerization and olefins homopolymerization | UNIVERSITA' DEGLI STUDI DI TRIESTE (IT) | 2025-11-11 | — | — | US | disclosed |
| WO-2024262906-A1 | RUTHENIUM COMPLEX COMPOUND, CATALYST COMPRISING SAME, AND METHOD FOR SYNTHESIZING RUTHENIUM COMPLEX COMPOUND | 포항공과대학교 산학협력단 | 2024-12-26 | — | — | WO | disclosed |
| EP-4107195-B1 | CATALYSTS AND PROCESS FOR OLEFINS AND POLAR VINYL MONOMERS COPOLYMERIZATION AND OLEFINS HOMOPOLYMERIZATION | UNIV DEGLI STUDI DI TRIESTE (IT) | 2024-11-20 | — | — | EP | disclosed |
| US-20240217976-A2 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240217976-A2 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20230125359-A1 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230053987-A1 | CATALYSTS AND PROCESS FOR OLEFINS AND POLAR VINYL MONOMERS COPOLYMERIZATION AND OLEFINS HOMOPOLYMERIZATION | UNIVERSITA' DEGLI STUDI DI TRIESTE (IT) | 2023-02-23 | — | — | US | disclosed |
| US-11560383-B2 | Compound and polymer compound containing the compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2023-01-24 | — | — | US | disclosed |
| EP-4107195-A1 | CATALYSTS AND PROCESS FOR OLEFINS AND POLAR VINYL MONOMERS COPOLYMERIZATION AND OLEFINS HOMOPOLYMERIZATION | UNIVERSITA' DEGLI STUDI DI TRIESTE (IT) | 2022-12-28 | — | — | EP | disclosed |
| CN-114634436-B | Ruthenium-containing catalyst, and preparation method and application thereof | 安徽泽升科技有限公司 | 2022-12-02 | — | — | CN | disclosed |
| EP-0987254-B1 | NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME | KOWA CO (JP) | 2004-12-22 | — | — | EP | disclosed |
| EP-1431294-A1 | VASCULAR WALL-SELECTIVE ACAT INHIBITOR | Kowa Company Ltd. (JP) | 2004-06-23 | — | — | EP | disclosed |
| US-20040038987-A1 | Novel cyclic diamine compounds and medicine containing the same | KOWA COMPANY, LTD. (JP) | 2004-02-26 | — | — | US | disclosed |
| EP-1179025-A1 | SUPPORTED CATALYSTS AND OLEFIN POLYMERIZATION PROCESSES UTILIZING SAME | Cryovac, Inc. (US) | 2002-02-13 | — | — | EP | disclosed |
| EP-1171481-A1 | SUPPORTED CATALYSTS AND OLEFIN POLYMERIZATION PROCESSES UTILIZING SAME | Cryovac, Inc. (US) | 2002-01-16 | — | — | EP | disclosed |
| US-6197714-B1 | USEFUL IN SLURRY AND GAS PHASE POLYMERIZATION OF OLEFINS | CRYOVAC, INC. | 2001-03-06 | — | — | US | disclosed |
| US-6197715-B1 | USEFUL IN SLURRY AND GAS PHASE POLYMERIZATION OF OLEFINS | CRYOVAC, INC. | 2001-03-06 | — | — | US | disclosed |
| WO-2000056787-A1 | SUPPORTED CATALYSTS AND OLEFIN POLYMERIZATION PROCESSES UTILIZING SAME | CRYOVAC, INC. (US) | 2000-09-28 | — | — | WO | disclosed |
| WO-2000056786-A1 | SUPPORTED CATALYSTS AND OLEFIN POLYMERIZATION PROCESSES UTILIZING SAME | CRYOVAC, INC. (US) | 2000-09-28 | — | — | WO | disclosed |
| EP-0987254-A1 | NOVEL CYCLIC DIAMINE COMPOUNDS AND MEDICINE CONTAINING THE SAME | Kowa Co., Ltd. (JP) | 2000-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11560383-B2 | Compound and polymer compound containing the compound | RAD51, MDM2, UBE2D3 | CA1 2433/4885CA2 3670/4885GABRA1 4765/4885 |
| US-20230125359-A1 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | RAD51, UBE2D3, MDM2 | CA1 2345/4885CA2 3596/4885GABRA1 4752/4885 |
| US-20240217976-A2 | COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND | RAD51, MDM2, UBE2D3 | CA1 2403/4885CA2 3628/4885GABRA1 4768/4885 |
| US-20040038987-A1 | Novel cyclic diamine compounds and medicine containing the same | LCAT, ACAT2, ACAT1 | CA1 709/4885CA2 726/4885GABRA1 3225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.